| scholarly article | Q13442814 |
| P50 | author | Shitij Kapur | Q20713543 |
| Pierre-Paul Rompré | Q113488612 | ||
| P2093 | author name string | Faïza Benaliouad | |
| P2860 | cites work | The role of serotonin in antipsychotic drug action | Q33702888 |
| The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics? | Q33762791 | ||
| Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine | Q34048732 | ||
| The medial prefrontal cortex as a part of the brain reward system | Q34057302 | ||
| Increased dopamine and serotonin metabolism in rat nucleus accumbens produced by intracranial self-stimulation of medial forebrain bundle as measured by in vivo microdialysis | Q34416926 | ||
| Dopamine receptor sub-types involvement in nucleus accumbens and ventral tegmentum but not in medial prefrontal cortex: on self-stimulation of lateral hypothalamus and ventral mesencephalon | Q34424542 | ||
| Brain dopamine and reward | Q34498922 | ||
| Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. | Q35165445 | ||
| Half a century of antipsychotics and still a central role for dopamine D2 receptors | Q35595235 | ||
| Neuroleptic dysphoria: towards a new synthesis | Q35597237 | ||
| Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications | Q35805891 | ||
| Elevated dopa decarboxylase activity in living brain of patients with psychosis | Q35927690 | ||
| Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist. | Q36817534 | ||
| Multiple reward systems and the prefrontal cortex | Q38715702 | ||
| Neurotransmitters, pathways and circuits as the neural substrates of self-stimulation of the prefrontal cortex: facts and speculations | Q39461057 | ||
| Dopamine receptors and the dopamine hypothesis of schizophrenia | Q39471744 | ||
| Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors | Q40691612 | ||
| Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials | Q40824415 | ||
| The influence of amphetamine on preference for lateral hypothalamic versus prefrontal cortex or ventral tegmental area self-stimulation | Q41562316 | ||
| Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function | Q42488294 | ||
| Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats. | Q43590182 | ||
| 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner | Q44100868 | ||
| SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens | Q44133491 | ||
| Psychosis and drug dependence: results from a national survey of prisoners | Q44201523 | ||
| Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy | Q44329097 | ||
| 5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens | Q44413951 | ||
| The substrates for self-stimulation of the lateral hypothalamus and medial prefrontal cortex: a comparison of strength-duration characteristics | Q44686902 | ||
| 5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat. | Q44771369 | ||
| Second-generation antipsychotics: looking beyond efficacy | Q44937604 | ||
| Regional neuroleptic microinjections indicate a role for nucleus accumbens in lateral hypothalamic self-stimulation reward. | Q45093035 | ||
| The curve-shift paradigm in self-stimulation | Q46553216 | ||
| Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function | Q46688426 | ||
| The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro | Q46696441 | ||
| Rostral-caudal differences in effects of nucleus accumbens amphetamine on VTA ICSS. | Q48140825 | ||
| Prefrontal cortex infusions of SCH 23390 cause immediate and delayed effects on ventral tegmental area stimulation reward | Q48356740 | ||
| Differential effect of self-stimulation on dopamine release and metabolism in the rat medial frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis | Q48509731 | ||
| The involvement of dopamine D2 receptors, but not D3 or D4 receptors, in the rewarding effect of brain stimulation in the rat. | Q48682275 | ||
| Affinity for the dopamine D2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation | Q48722660 | ||
| Ketamine blocks the plasticity associated with prefrontal cortex self-stimulation | Q48848015 | ||
| Application of in vivo electrochemistry to the measurement of changes in dopamine release during intracranial self-stimulation | Q48910046 | ||
| Effect of pimozide on self-stimulation threshold under a continuous and fixed-interval schedule of reinforcement | Q48950558 | ||
| Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907. | Q50110215 | ||
| Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat. | Q50112499 | ||
| Intracranial self-stimulation increases differentially in vivo hydroxylation of tyrosine but similarly in vivo hydroxylation of tryptophan in rat medial prefrontal cortex, nucleus accumbens and striatum. | Q52168637 | ||
| Behavioral evidence of depolarization block of dopamine neurons after chronic treatment with haloperidol and clozapine. | Q52171442 | ||
| Psychostimulant-like effect of central microinjection of neurotensin on brain stimulation reward. | Q52210903 | ||
| Effects of nucleus accumbens amphetamine on lateral hypothalamic brain stimulation reward. | Q52250260 | ||
| Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. | Q52506986 | ||
| Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system | Q70812727 | ||
| Fos expression following self-stimulation of the medial prefrontal cortex | Q73340492 | ||
| The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies | Q73553209 | ||
| Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area | Q73763841 | ||
| Evidence for functional interactions between 5-HT1A and 5-HT2A receptors in rat thermoregulatory mechanisms | Q74467746 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 551-561 | |
| P577 | publication date | 2006-06-14 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward | |
| P478 | volume | 32 |
| Q92573383 | 5-HT2A receptors modulate dopamine D2-mediated maternal effects |
| Q26745506 | Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms |
| Q45760377 | Clozapine increases reward evaluation but not overall ingestive behaviour in rats licking for sucrose |
| Q30365347 | Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning. |
| Q37417150 | Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in rats |
| Q43111580 | Effects of blockade of central dopamine D1 and D2 receptors on thermoregulation, metabolic rate and running performance |
| Q52301619 | Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions. |
| Q33845750 | Intracranial self-stimulation to evaluate abuse potential of drugs. |
| Q34314781 | Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio. |
| Q55279176 | On the Drive Specificity of Freudian Drives for the Generation of SEEKING Activities: The Importance of the Underestimated Imperative Motor Factor. |
| Q34512547 | Open-label pilot study of quetiapine treatment for cannabis dependence |
| Q37212064 | Opposite modulation of brain stimulation reward by NMDA and AMPA receptors in the ventral tegmental area |
| Q36655856 | Preclinical Abuse Potential Assessment of Flibanserin: Effects on Intracranial Self-Stimulation in Female and Male Rats. |
| Q42395737 | Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration |
| Q37553137 | Regulation of motivation for food by neuromedin U in the paraventricular nucleus and the dorsal raphe nucleus |
| Q34122658 | Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine |
| Q33318080 | Serotonin, inhibition, and negative mood |
Search more.